Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study. (2022)

First Author: Brandi ML
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00223-022-01006-7

PubMed Identifier: 35927518

Publication URI: http://europepmc.org/abstract/MED/35927518

Type: Journal Article/Review

Volume: 111

Parent Publication: Calcified tissue international

Issue: 4

ISSN: 0171-967X